Sign in

CIK 0001933414

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Mineralys Therapeutics, Inc.

Sign in to watch
Ticker
MLYS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
841966887
Phone
+1 888-378-6240
Business address
150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,209,843
in 4 filings, $2.2M under 10b5-1 plans

Net −$5,209,843. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-19 SBLENDORIO GLENN Director Grant or award +6,200 6,200
2026-02-19 SBLENDORIO GLENN Director Grant or award · Stock Option +8,300 8,300
2025-02-13 SBLENDORIO GLENN Director Grant or award · Stock Option +32,900 32,900
2024-05-22 SBLENDORIO GLENN Director Grant or award · Stock Option +22,000 22,000
2023-09-13 SBLENDORIO GLENN Director Grant or award · Stock Option +44,000 44,000

Page 1 of 1 · 5 trades